Show notes
Boston. San Francisco. Beijing? The global biotech industry has long been concentrated in a handful of cities. But which emerging hubs could become dominant forces in biotech in the decades ahead? In this week’s episode of “The Top Line,” Fierce Biotech’s Darren Incorvaia and Will Maddox discuss a new Fierce special report identifying five cities with the potential to become major forces in the global biotech industry.
Transcript
Transcript not available for this episode yet.
More from The Top Line
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
Aug 7, 202620 min
The next frontier in patient support: Connected data, AI and personalized engagement (Sponsored)
Aug 6, 202626 min
Inside Noble’s connected approach to patient support (Sponsored)
Aug 3, 202615 min
Psychedelics, peptides and GLP-1s
Jul 31, 202625 min
GSK’s first lung cancer approval, a new IPO path and more
Jul 24, 202611 min